SUCAMPO PHARMACEUTICALS INC's ticker is SCMP and the CUSIP is 864909106. A total of 120 filers reported holding SUCAMPO PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 0.72 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $719,000 | +72.8% | 40,062 | +30.5% | 0.02% | -20.0% |
| Q4 2016 | $416,000 | -17.8% | 30,694 | -25.3% | 0.03% | -9.1% |
| Q3 2016 | $506,000 | +12.2% | 41,096 | 0.0% | 0.03% | +6.5% |
| Q2 2016 | $451,000 | +5537.5% | 41,096 | +5314.5% | 0.03% | +3000.0% |
| Q1 2016 | $8,000 | -38.5% | 759 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $13,000 | -95.9% | 759 | -95.2% | 0.00% | -92.3% |
| Q3 2015 | $314,000 | – | 15,810 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 51,630 | $336,000 | 0.32% |
| Granahan Investment Management | 1,389,775 | $9,034,000 | 0.28% |
| Visium Asset Management, LP | 1,806,200 | $11,740,000 | 0.17% |
| MENTA CAPITAL LLC | 96,507 | $627,000 | 0.10% |
| OBERWEIS ASSET MANAGEMENT INC/ | 51,700 | $336,000 | 0.09% |
| CADENCE CAPITAL MANAGEMENT LLC | 152,632 | $992,000 | 0.05% |
| Spark Investment Management LLC | 41,200 | $267,000 | 0.04% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 27,600 | $179,000 | 0.02% |
| GLOBEFLEX CAPITAL L P | 29,800 | $194,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 130,500 | $848,000 | 0.02% |